Home > > North America And Global Clinical Diagnostics Market- Size, Share, Growth Rate, and Forecast
The North America Clinical Diagnostics market was valued at $38.5 Million in 2024, and is projected to reach $39.6 Million by 2031 growing at a CAGR of 0.46% from 2025 to 2031. Instruments segment is expected to be the highest contributor to this market, with $20.8 Million in 2024, and is anticipated to reach $20.9 by 2031, registering a CAGR of 0.09%. Reagents segment is anticipated to reach $14.2 Million by 2031 with the highest CAGR of 1.45%. Instruments and Reagents segments collectively expected to account for about 87.6% share of the North America Clinical Diagnostics market in 2024, with the former constituting around 54.2% share. Reagents and Instruments segments are expected to witness significant growth rates at a CAGR of 1.45% and 0.09% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 87.6% in the overall North America Clinical Diagnostics market in 2024, and is anticipated to reach 88.7% by 2031. -------------Product Instruments Reagents Services Technology Immunoassay Hematology Clinical Chemistry Molecular Diagnostics Coagulation Microbiology Other Technologies Application Infectious Disease Diabetes Oncology Cardiology Nephrology Autoimmune Disease Drug Testing Other Applications BY REGION North America U.s. Canada Europe Germany U.k. France Italy Spain Rest of Europe Asia China Japan South Korea India Indonesia Rest of Asia Middle East & Africa Brazil Mexico South Africa Australia Rest of MENA